Given the role of STAT proteins in contributing to cell survival, oncogenic activation of these factors, especially STAT-3, has been found in diverse types of tumors including hepatocellular carcinoma, colorectal cancer, breast cancer, bladder cancer and hematological malignancies [55,64]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.